Related Experiment Videos
[How to establish GCP-units in Denmark?]
Kim Krogsgaard1, Per Buch Andreasen
1Klinisk Forskningsenhed, H:S Hvidovre Hospital, Afsnit 136, DK-2650 Hvidovre. kim.krogsgaard@hh.hosp.dk
Ugeskrift for Laeger
|May 22, 2003
Summary
New EU regulations require investigator-initiated drug trials to follow Good Clinical Practice (GCP) guidelines. To support compliance, Denmark proposes establishing regional GCP units at university hospitals, costing approximately DDK 7.5-10 million annually.
Area of Science:
- Clinical Research
- Regulatory Compliance
- Drug Trials
Context:
- A new EU Directive mandates adherence to Good Clinical Practice (GCP) for investigator-initiated drug trials from May 2004.
- This necessitates trials being conducted under Standard Operating Procedures (SOPs), with monitoring and auditing.
- In 2001, Danish investigators initiated 73 drug trials, highlighting the need for support.
Purpose:
- To propose the establishment of 3-4 regional Good Clinical Practice (GCP) units.
- These units will provide essential GCP services and guidance to investigators.
- The goal is to ensure compliance with the new EU Directive.
Summary:
- The proposed regional GCP units will offer crucial support for investigator-initiated drug trials.
- Implementation involves establishing 3-4 units across Denmark's university hospitals.
- This initiative aims to facilitate adherence to GCP guidelines and SOPs.
Impact:
- Ensures investigator-initiated drug trials meet stringent Good Clinical Practice (GCP) standards.
- Enhances the quality and reliability of clinical trial data in Denmark.
- Requires an estimated annual investment of DDK 7.5 to 10 million for operational costs.